Fearon ER - Search Results

1

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: fearon er. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

2

The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin.

Dillon DA, D'Aquila T, Reynolds AB, Fearon ER, Rimm DL. Dillon DA, et al. Among authors: fearon er. Am J Pathol. 1998 Jan;152(1):75-82. Am J Pathol. 1998. PMID: 9422525 Free PMC article.

3

Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.

Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER. Rimm DL, et al. Among authors: fearon er. Am J Pathol. 1999 Feb;154(2):325-9. doi: 10.1016/s0002-9440(10)65278-9. Am J Pathol. 1999. PMID: 10027390 Free PMC article.

4

Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.

Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. Pierceall WE, et al. Among authors: fearon er. Oncogene. 1995 Oct 5;11(7):1319-26. Oncogene. 1995. PMID: 7478552

5

Transcriptional defects underlie loss of E-cadherin expression in breast cancer.

Ji X, Woodard AS, Rimm DL, Fearon ER. Ji X, et al. Among authors: fearon er. Cell Growth Differ. 1997 Jul;8(7):773-8. Cell Growth Differ. 1997. PMID: 9218871

6

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER. Caca K, et al. Among authors: fearon er. Cell Growth Differ. 1999 Jun;10(6):369-76. Cell Growth Differ. 1999. PMID: 10392898

7

Loss of DCC expression and glioma progression.

Reyes-Mugica M, Rieger-Christ K, Ohgaki H, Ekstrand BC, Helie M, Kleinman G, Yahanda A, Fearon ER, Kleihues P, Reale MA. Reyes-Mugica M, et al. Among authors: fearon er. Cancer Res. 1997 Feb 1;57(3):382-6. Cancer Res. 1997. PMID: 9012460

8

Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.

Reale MA, Hu G, Zafar AI, Getzenberg RH, Levine SM, Fearon ER. Reale MA, et al. Among authors: fearon er. Cancer Res. 1994 Aug 15;54(16):4493-501. Cancer Res. 1994. PMID: 8044801

9

Loss of DCC expression in neuroblastoma is associated with disease dissemination.

Reale MA, Reyes-Mugica M, Pierceall WE, Rubinstein MC, Hedrick L, Cohn SL, Nakagawara A, Brodeur GM, Fearon ER. Reale MA, et al. Among authors: fearon er. Clin Cancer Res. 1996 Jul;2(7):1097-102. Clin Cancer Res. 1996. PMID: 9816273

10

The deleted in colorectal cancer (DCC) gene: a candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules.

Fearon ER, Pierceall WE. Fearon ER, et al. Cancer Surv. 1995;24:3-17. Cancer Surv. 1995. PMID: 7553661 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page